So in honor of every spell gone wrong, every mysterious bubbling flask, and every suspicious stew Snape definitely judged you ...

Beam Therapeutics (NASDAQ:BEAM) gains FDA orphan drug status for BEAM-101 to treat sickle cell disease. Read more here.

Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, ...